Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 30 Jun 2024 16:16:14 +0200Thu, 20 Jun 2024 15:50:00 +0200Human medicines European public assessment report (EPAR): Nintedanib Accord, nintedanib, Date of authorisation: 19/04/2024, Revision: 1, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/nintedanib-accordHuman medicines European public assessment report (EPAR): Nintedanib Accord, nintedanib, Date of authorisation: 19/04/2024, Revision: 1, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/nintedanib-accordThu, 20 Jun 2024 15:50:00 +0200Human medicineNintedanib Accord : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6179_en.pdfNintedanib Accord : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6179_en.pdfMon, 22 Apr 2024 10:32:03 +0200Human medicine